IDEAYA Biosciences (IDYA) Enterprise Value (2019 - 2025)
Historic Enterprise Value for IDEAYA Biosciences (IDYA) over the last 7 years, with Q4 2025 value amounting to -$639.4 million.
- IDEAYA Biosciences' Enterprise Value rose 546.06% to -$639.4 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$639.4 million, marking a year-over-year increase of 546.06%. This contributed to the annual value of -$639.4 million for FY2025, which is 546.06% up from last year.
- According to the latest figures from Q4 2025, IDEAYA Biosciences' Enterprise Value is -$639.4 million, which was up 546.06% from -$786.9 million recorded in Q3 2025.
- IDEAYA Biosciences' 5-year Enterprise Value high stood at -$246.8 million for Q4 2021, and its period low was -$920.0 million during Q3 2024.
- For the 5-year period, IDEAYA Biosciences' Enterprise Value averaged around -$498.6 million, with its median value being -$481.2 million (2023).
- As far as peak fluctuations go, IDEAYA Biosciences' Enterprise Value crashed by 24408.23% in 2021, and later soared by 1644.68% in 2022.
- Over the past 5 years, IDEAYA Biosciences' Enterprise Value (Quarter) stood at -$246.8 million in 2021, then crashed by 47.84% to -$364.8 million in 2022, then tumbled by 43.93% to -$525.1 million in 2023, then dropped by 28.79% to -$676.3 million in 2024, then grew by 5.46% to -$639.4 million in 2025.
- Its last three reported values are -$639.4 million in Q4 2025, -$786.9 million for Q3 2025, and -$669.7 million during Q2 2025.